Department of Pediatrics, Diabetes Center, University of Rome La Sapienza, Rome, Italy.
Diabetes Technol Ther. 2009 Dec;11(12):767-74. doi: 10.1089/dia.2009.0049.
This study analyzed the changes in insulin requirement in the transition from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII) and the differences through the CSII treatment in pediatric patients in different pubertal developmental stages.
We analyzed, through a longitudinal retrospective study, the insulin usage patterns and glycemic control of 40 patients with type 1 diabetes on CSII treatment for 12 months. The patients were subdivided in three groups: group A, 13 prepubertal subjects (Tanner stage I); group B, 15 pubertal subjects (Tanner stage II-IV); and group C, 12 postpubertal subjects (Tanner stage V).
During the transition from MDI to CSII, the insulin requirements decreased significantly by 21 +/- 5% (0.89 +/- 0.26 U/kg/day vs. 0.70 +/- 0.11 U/kg/day). Through the CSII treatment the percentage of total daily insulin delivered as the basal rate in groups A, B, and C was 54-60%, 52-54%, and 52-54%, respectively. The number of basal rates per day was significantly higher in groups A and B. The overall profile of basal rate differed among the groups. During the night, prepubertal patients required more insulin from 12 p.m. to 2 a.m., whereas pubertal and postpubertal patients required more insulin between 2-3 a.m. to 7 a.m. Prepubertal patients had a maximum basal rate between 9 a.m. to 12 a.m. and 2 p.m. to 4 p.m., in contrast to pubertal and postpubertal patients between 2 p.m. to 3 p.m. and 5 p.m. to 6 p.m. The number of "extra" boluses per day was significantly higher in groups B and C compared to group A.
Age-related differences exist in insulin usage patterns of pediatric patients on pump treatment. A greater knowledge of these variations may help to obtain optimum conditions in the CSII treatment in pediatric patients.
本研究分析了从多次皮下注射(MDI)过渡到连续皮下胰岛素输注(CSII)时胰岛素需求的变化,并比较了不同青春期发育阶段的儿科患者接受 CSII 治疗后的差异。
我们通过一项纵向回顾性研究,分析了 40 例接受 CSII 治疗 12 个月的 1 型糖尿病患者的胰岛素使用模式和血糖控制情况。这些患者被分为三组:A 组 13 例为青春期前儿童(Tanner Ⅰ期);B 组 15 例为青春期儿童(Tanner Ⅱ-Ⅳ期);C 组 12 例为青春期后儿童(Tanner Ⅴ期)。
从 MDI 过渡到 CSII 时,胰岛素需求量显著下降 21%±5%(0.89±0.26 U/kg/天比 0.70±0.11 U/kg/天)。通过 CSII 治疗,A、B、C 组中基础率占全天胰岛素总量的比例分别为 54-60%、52-54%和 52-54%。A 组和 B 组的基础率次数明显较高。各组的基础率总体分布不同。夜间,青春期前患者从 12 点到凌晨 2 点需要更多的胰岛素,而青春期和青春期后患者则需要更多的胰岛素从凌晨 2-3 点到早上 7 点。青春期前患者的最大基础率出现在上午 9 点到 12 点和下午 2 点到 4 点,而青春期和青春期后患者则出现在下午 2 点到 3 点和下午 5 点到 6 点。与 A 组相比,B 组和 C 组每天的“额外”胰岛素剂量明显更高。
接受泵治疗的儿科患者的胰岛素使用模式存在与年龄相关的差异。更好地了解这些差异可能有助于为儿科患者的 CSII 治疗获得最佳条件。